Fig. 4From: Cost-effectiveness of preemptive skin treatment to prevent skin-toxicity caused by panitumumab in third-line therapy for KRAS wild type metastatic colorectal cancer in JapanCost-effectiveness plane. JPY: Japanease yen, QALY: Quality adjusted life years, WTP: Willingness-to-payBack to article page